NuMi Rx is committed to operating a safe, legal, and transparent telehealth platform. We follow federal telehealth and pharmacy law, HIPAA, and the standards set by third-party certifiers including LegitScript.
All prescriptions are issued by clinicians licensed in the patient's state of residence. Provider licenses are verified and continuously monitored.
Medications are dispensed only by pharmacies licensed in the patient's state and, where applicable, registered with the DEA and FDA. We do not import medications.
In accordance with the Ryan Haight Online Pharmacy Consumer Protection Act, our providers do not prescribe Schedule II–V controlled substances over telehealth outside of legally permitted exceptions.
Our policies, provider oversight, marketing standards, and pharmacy partnerships are designed to meet LegitScript's Healthcare Merchant Certification standards.
PHI is encrypted in transit and at rest. Access is role-based and audited. All vendors handling PHI operate under Business Associate Agreements.
Our physical business address, ownership, medical director, refund and cancellation policies, and contact information are published and accurate.
Our clinical operations are overseen by a state-licensed Medical Director. Provider quality is monitored through peer review, prescribing audits, and adverse-event tracking.
NuMi Rx marketing is truthful, non-misleading, and includes required safety information and material risks. We do not make efficacy claims that are not supported by evidence, and we do not use before/after imagery or testimonials in a manner prohibited by state medical boards.
Certain treatments (including some GLP-1, peptide, and hormone formulations) may be prescribed as compounded medications from 503A or 503B pharmacies. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, efficacy, or quality. A licensed provider will discuss the risks and benefits before prescribing.
To report a safety concern, adverse event, or compliance issue, contact compliance@numirx.com or call 813.812.1833. You may also report concerns to your state medical board or to the FDA MedWatch program at 1-800-FDA-1088.
Clinical operations are overseen by our named Medical Director, a physician licensed in the State of Florida. Medical Director name and Florida license number: [TO BE PROVIDED]. This information will be published here and made available to LegitScript and state boards upon request.
Medications are dispensed by Rush Pharmacy, a U.S.-licensed pharmacy. See our Pharmacy Partner page for licensing details and states served.
Clinical services are delivered by independent providers through LocumTele. Every provider is licensed in the patient's state of residence and credentials are continuously monitored.
NuMi Rx currently serves patients in 47 U.S. states. Services are not available in California, South Carolina, or New Jersey. Treatment availability within a state is also subject to clinical appropriateness.
Refills are authorized only by the prescribing provider based on clinical review and adherence. Government-issued photo ID is required at intake and may be re-verified. Early refills are not permitted outside of medically justified exceptions. Prescription transfers to or from outside pharmacies are handled directly by Rush Pharmacy.
NuMi Rx, Inc.
3909 W Kennedy Blvd, Space B
Tampa, FL 33609
Phone: 813.812.1833
Email: support@numirx.com
